MNKD Q2 2018 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$841M

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+80.0% YoY

Gross Profit

-$1M-30.9% margin

Operating Income

-$21M-527.5% margin

Net Income

-$23M-582.5% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

+12.4%

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$27M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$62M

Total Liabilities

$269M

Stockholders' Equity

-$207M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$2M	+80.0%
Gross Profit	-$1M	-$3M	+58.9%
Operating Income	-$21M	-$32M	+34.9%
Net Income	-$23M	-$35M	+35.8%

Revenue Segments

Product

$4M96%

License

$87,0002%

Product And Service Other

$53,0001%